Skip to main content
Arcutis Biotherapeutics, Inc. logo

Arcutis Biotherapeutics, Inc. — Investor Relations & Filings

Ticker · ARQT ISIN · US03969K1088 US Manufacturing
Filings indexed 755 across all filing types
Latest filing 2026-04-21 Registration Form
Country US United States of America
Listing US ARQT

About Arcutis Biotherapeutics, Inc.

https://arcutis.com/

Arcutis Biotherapeutics, Inc. is a commercial-stage medical dermatology company focused on developing and commercializing treatments for immune-mediated skin diseases. The company champions innovation to address unmet needs for individuals with chronic inflammatory skin conditions. Its pipeline includes novel topical therapies targeting biologically validated pathways for diseases such as plaque psoriasis, atopic dermatitis, and seborrheic dermatitis. Arcutis aims to simplify complex disease management for patients and healthcare professionals by developing effective and well-tolerated treatments.

Recent filings

Filing Released Lang Actions
S-8 - Arcutis Biotherapeutics, Inc. (0001787306) (Filer)
Registration Form
2026-04-21 English
DEF 14A - Arcutis Biotherapeutics, Inc. (0001787306) (Filer)
Proxy Solicitation & Information Statement
2026-04-21 English
SCHEDULE 13G/A - Arcutis Biotherapeutics, Inc. (0001787306) (Subject)
Major Shareholding Notification
2026-03-26 English
4 - ARCUTIS BIOTHERAPEUTICS, INC. (0001787306) (Filer)
Director's Dealing
2026-03-04 English
4 - ARCUTIS BIOTHERAPEUTICS, INC. (0001787306) (Filer)
Director's Dealing
2026-03-04 English
4 - ARCUTIS BIOTHERAPEUTICS, INC. (0001787306) (Filer)
Director's Dealing
2026-03-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.